This review prioritized the myostatin pathway over other anabolic mechanisms, such as IGF-1/AKT signaling, due to its central role in negatively regulating skeletal muscle mass and its disease-specific relevance in SMA. Here, MSTN is linked to proximal spinal muscular atrophy.